###begin article-title 0
###xml 20 25 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Anx2 Interacts with HIV-1 Gag at Phosphatidylinositol (4,5) Bisphosphate-Containing Lipid Rafts and Increases Viral Production in 293T Cells
###end article-title 0
###begin p 1
Conceived and designed the experiments: AVH EVR FGS. Performed the experiments: AVH EVR TH. Analyzed the data: AVH EVR. Wrote the paper: AVH EVR FGS.
###end p 1
###begin p 2
###xml 38 43 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 82 87 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 341 344 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 368 373 <span type="species:ncbi:9606">human</span>
###xml 752 757 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 987 992 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1150 1155 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The neuronal damage characteristic of HIV-1-mediated CNS diseases is inflicted by HIV-1 infected brain macrophages. Several steps of viral replication, including assembly and budding, differ between macrophages and T cells; it is likely that cell-specific host factors mediate these differences. We previously defined Annexin 2 (Anx2) as an HIV Gag binding partner in human monocyte-derived macrophages (MDMs) that promotes proper viral assembly. Anx2, a calcium-dependent membrane-binding protein that can aggregate phospholipid-containing lipid rafts, is expressed to high levels in macrophages, but not in T lymphocytes or the 293T cell line. Here, we use bimolecular fluorescence complementation in the 293T cell model to demonstrate that Anx2 and HIV-1 Gag interact at the phosphatidylinositol (4,5) bisphosphate-containing lipid raft membrane domains at which Gag mediates viral assembly. Furthermore, we demonstrate that Anx2 expression in 293T cells increases Gag processing and HIV-1 production. These data provide new evidence that Anx2, by interacting with Gag at the membranes that support viral assembly, functions in the late stages of HIV-1 replication.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 159 162 159 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Antinori1">[1]</xref>
###xml 164 167 164 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Williams1">[2]</xref>
###xml 416 419 416 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Williams1">[2]</xref>
###xml 421 424 421 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-FischerSmith1">[3]</xref>
###xml 587 590 587 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Williams1">[2]</xref>
###xml 592 595 592 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-GonzalezScarano1">[4]</xref>
###xml 727 730 727 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-An1">[5]</xref>
###xml 732 735 732 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Davis1">[6]</xref>
###xml 894 897 894 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Stevenson1">[7]</xref>
###xml 33 38 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 74 77 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 610 613 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 997 1000 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1145 1148 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Direct infection of the brain by HIV-1 causes the AIDS-definining illness HIV-associated dementia (HAD) as well as a spectrum of motor and cognitive disorders [1], [2]. Though neuronal death and damage are a hallmark of the pathology associated with HAD, neurons themselves are not infected. Instead, monocyte-derived macrophages (MDMs) and parenchymal microglia are the productively infected cells within the brain [2], [3], and it is the viral proteins and inflammatory mediators released by these cells that damage neurons either directly or by causing glial dysfunction (reviewed in [2], [4]. Moreover, as HIV enters the brain within weeks after initial infection and potentially years before neurological symptoms develop [5], [6], it is likely that brain macrophages serve as long-lived viral reservoirs in the immunologically and pharmacologically protected central nervous system (CNS) [7]. Given the critical role of macrophages in the neuropathogenesis of AIDS, understanding aspects of HIV replication that may be unique to these cells is a crucial step toward developing more specific and effective antiretroviral therapies to treat HIV-mediated CNS disease.
###end p 4
###begin p 5
###xml 275 278 275 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Verani1">[8]</xref>
###xml 617 620 617 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ryzhova1">[9]</xref>
###xml 19 22 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 590 595 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Several aspects of HIV replication differ in macrophages from the more extensively studied CD4+ T cells, including the coreceptor used for entry, the mechanisms regulating nuclear import and viral transcription, and the cellular location of assembly and budding (reviewed in [8]). As these cells serve vastly different functions in the immune response, it is likely that many of the differences in viral replication are due to differential protein expression and regulation between the two cell types. We recently undertook studies to identify macrophage-specific proteins that function in HIV-1 assembly and budding [9].
###end p 5
###begin p 6
###xml 55 58 55 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Gheysen1">[10]</xref>
###xml 276 280 276 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Adamson1">[11]</xref>
###xml 350 353 350 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 assembly is mediated by the viral polyprotein p55Gag, the only viral protein necessary for the formation and release of virion-like particles [10]. Gag is synthesized as a 55 kD precursor with four domains that mediate the steps of virion assembly, budding, and release [11]. During or immediately after assembly, the viral protease cleaves p55Gag into the matrix (MA, p17), capsid (CA, p24), and nucleocapsid (NC, p7) proteins that form the structure of the mature, infectious virion.
###end p 6
###begin p 7
###xml 243 244 243 244 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 246 250 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Leung1">[12]</xref>
###xml 251 255 251 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ono3">[24]</xref>
###xml 327 331 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Booth1">[25]</xref>
###xml 332 336 332 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Nydegger2">[27]</xref>
###xml 683 686 683 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ryzhova1">[9]</xref>
###xml 688 692 688 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Pornillos1">[28]</xref>
###xml 753 756 753 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ryzhova1">[9]</xref>
###xml 523 528 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Recent evidence has shown that Gag preferentially mediates viral assembly at specific membrane microdomains. These domains are cholesterol-enriched lipid rafts that contain the phospholipid phosphatidylinositol (4,5) bisphosphate (PtdIns(4,5)P2) [12]-[24] and that are enriched in endosomal tetraspannins and sorting machinery [25]-[27]. Host proteins that regulate membrane phospholipids, cholesterol, and endosomal components may thus play important roles in the late stages of viral replication. We identified Anx2 as a HIV-1 Gag-interacting protein in productively infected MDMs in an effort to discover cellular proteins that influence viral assembly and budding in these cells [9], [28]. Anx2 is expressed highly in macrophages but not in T cells [9], and the described functions of Anx2 make it a good candidate as a possible regulator protein.
###end p 7
###begin p 8
###xml 264 268 264 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Brownstein1">[29]</xref>
###xml 308 312 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Li1">[30]</xref>
###xml 314 318 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Swisher1">[31]</xref>
###xml 400 404 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ma1">[32]</xref>
###xml 458 462 458 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Emans1">[33]</xref>
###xml 535 539 535 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Gruenberg1">[34]</xref>
###xml 540 544 540 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Zobiack1">[37]</xref>
###xml 794 798 794 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-AyalaSanmartin1">[38]</xref>
###xml 799 803 799 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-ChasserotGolaz1">[40]</xref>
###xml 863 867 863 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Brown1">[41]</xref>
###xml 868 872 868 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Salaun1">[44]</xref>
###xml 926 927 926 927 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 954 958 954 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Gokhale1">[45]</xref>
###xml 1053 1054 1053 1054 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 356 361 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1130 1135 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Anx2 is a multifunctional calcium-dependent membrane-binding protein with roles in both extracellular signaling and the intracellular regulation of membrane composition and dynamics. Extracellular and cell-surface associated Anx2 is involved in plasmin generation [29] and cytokine production by macrophages [30], [31], and has been proposed to facilitate HIV-1 binding to and entry into macrophages [32]. In the cytoplasm, Anx2 binds to endosomal membranes [33] and is important in both early and late phases of the endocytic pathway [34]-[37]. The mechanisms by which Anx2 functions in these dynamic membrane events may involve one of several abilities to influence membrane composition and aggregation. Anx2 can mediate the lateral association and stability of cholesterol-rich microdomains [38]-[40], concentration of proteins destined for endocytic pathways [41]-[44] and induction of the formation of stable PtdIns(4,5)P2 clusters within membranes [45]. The ability of Anx2 to regulate endosomal trafficking as well as cholesterol and PtdIns(4,5)P2 within cellular membranes make it an attractive host protein important for HIV-1 assembly and budding in macrophages.
###end p 8
###begin p 9
###xml 25 28 25 28 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ryzhova1">[9]</xref>
###xml 106 111 106 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">first</italic>
###xml 324 328 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Albright1">[46]</xref>
###xml 330 336 330 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">second</italic>
###xml 487 490 487 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ryzhova1">[9]</xref>
###xml 492 496 492 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Nguyen2">[47]</xref>
###xml 497 501 497 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Raposo1">[50]</xref>
###xml 507 512 507 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">third</italic>
###xml 798 802 798 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Chertova1">[51]</xref>
###xml 269 272 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 778 783 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Our previous experiments [9] suggested a role for Anx2 in viral assembly based on the following evidence: first, Anx2 and Gag were only co-immunoprecipitated in activated, productively infected macrophages and not in quiescent macrophages in which there was a block to HIV replication at a late step in the viral life cycle [46]; second, both Gag and Anx2 colocated with CD63+ late endosomal compartments in infected macrophages, the same compartments in which mature virions accumulate [9], [47]-[50]; and third, downregulation of Anx2 resulted in decreased viral replication, aberrant Gag processing, and failure of mature virions to accumulate in intracellular vesicles. A subsequent study by Chertova et al. demonstrated that Anx2 is incorporated into virions released from HIV-1 infected MDMs [51], presenting further evidence that it is present at the site of viral assembly.
###end p 9
###begin p 10
###xml 377 378 377 378 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 378 382 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ono2">[20]</xref>
###xml 384 388 384 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Chukkapalli1">[22]</xref>
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Liao1">[16]</xref>
###xml 408 412 408 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Liao2">[17]</xref>
###xml 414 418 414 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ono1">[19]</xref>
###xml 420 424 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ono3">[24]</xref>
###xml 444 448 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Alroy1">[52]</xref>
###xml 449 453 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ryo1">[58]</xref>
###xml 957 958 957 958 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 457 462 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 801 806 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 989 992 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1207 1212 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1264 1269 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
As MDMs are difficult to transfect and display donor-to-donor variability in protein expression, we chose here to use the 293T cell line to further define the role of Anx2 in viral replication. Multiple recent studies have taken advantage of the ease of transfection of epithelial cell lines such as 293T and HeLa cells to study the role of host components such as PtdIns(4,5)P2[20], [22], cholesterol [16], [17], [19], [24], and host proteins [52]-[58] in HIV-1 assembly and budding. Furthermore, as 293T cells do not express endogenous Anx2, they allow us to control Anx2 expression levels and give us a model in which to study the effects of Anx2 gain-of-function on viral replication. Based on our previous observations in MDMs, we hypothesized that Anx2 helps form a membrane scaffold from which HIV-1 buds. Here, we investigate the location and nature of the membranes at which Anx2 and Gag interact and confirm these proteins bind at the PtdIns(4,5)P2-enriched lipid rafts at which HIV assembles. Furthermore, in accordance with our loss-of-function findings in MDMs, we report that Anx2 gain-of-function enhances Gag processing and viral production. These studies contribute to our understanding of HIV-1 replication in macrophages, the major mediators of HIV-1 associated neurologic disease.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
Anx2 was incorporated into virions produced by MDMs and 293T cells
###end title 12
###begin p 13
###xml 93 96 93 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ryzhova1">[9]</xref>
###xml 267 270 267 270 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 359 363 359 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Li2">[59]</xref>
###xml 365 369 365 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Li3">[60]</xref>
###xml 634 635 634 635 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 635 642 635 642 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1A</bold>
###xml 635 642 635 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g001"><bold>Fig. 1A</bold></xref>
###xml 642 643 642 643 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 262 265 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 320 327 <span type="species:ncbi:9606">patient</span>
###xml 491 494 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
We previously reported that Anx2 and Gag co-precipitated when co-transfected into 293T cells [9]. To examine whether Anx2 and Gag interact at the site of viral assembly, we cotransfected 293T cells with a molecular clone expressing Anx2 and the infectious clone HIV-1YU2, an M-tropic provirus cloned from the brain of a patient with the AIDS dementia complex [59], [60]. Transient transfection of Anx2 into these cells resulted in Anx2 expression levels comparable to that in both mock- and HIV-infected macrophages with some experiment-to-experiment variability much like the donor-to-donor variability seen with primary macrophages (Fig. 1A). Untransfected 293T cells expressed no detectable endogenous Anx2.
###end p 13
###begin title 14
Anx2 was present in virions released from 293T cells and localized with Gag to detergent resistant membrane domains.
###end title 14
###begin p 15
###xml 75 78 75 78 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 94 97 94 97 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 152 155 152 155 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 391 394 391 394 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 406 409 406 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 992 995 988 991 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 1011 1014 1007 1010 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 1400 1403 1392 1395 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 1798 1801 1790 1793 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 2066 2069 2058 2061 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 2294 2297 2286 2289 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 2446 2467 2438 2459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">materials and methods</xref>
###xml 70 73 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 89 92 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 147 150 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 248 253 <span type="species:ncbi:9606">Human</span>
###xml 386 389 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 987 990 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1006 1009 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1129 1132 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1395 1398 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1793 1796 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1879 1882 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 2289 2292 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(A) Western blot analysis of lysates from 293T cells transfected with HIV-1YU2+Vector or HIV-1YU2+Anx2 and MDMs either uninfected or infected with HIV-1YU2. Anx2 expression in transfected 293T cells was comparable to that in MDMs. (B) (Left Panel) Human peripheral blood mononuclear cells (PBMCs) were differentiated into monocyte-derived macrophages (MDMs) and infected for 48 hr with HIV-1YU2 (200 ng p24Gag/six-well plate well). The supernatants collected eleven days after infection were clarified, and aliquots of 1 mL were passed through 0.45 microM filters. Virus pellets were obtained by ultracentrifugation of the filtered supernatants and analyzed by SDS-PAGE and western blot. Anx2 was present in the pellets obtained from the supernatants of infected macrophages but not in those from uninfected macrophages. GAPDH was not detected, ensuring that the pellet was not contaminated with free cellular material. (Right Panel) 293T cells were cotransfected with plasmids encoding HIV-1YU2 and Anx2, HIV-1YU2 and empty vector, or Anx2 alone. As indicated, some cells were treated with 50 microM indinavir sulfate (IND - an HIV protease inhibitor) immediately after transfection. Thirty-six hours later, the supernatants were collected and virions were pelleted and analyzed in the same manner as those from the MDMs. Anx2 was also present in the pellets from 293T cells cotransfected with HIV-1YU2 and Anx2 but not under the control conditions. Indinavir sulfate had no effect on the apparent level of Anx2 in the virion pellet over several experiments. In the absence of protease inhibitor, the Gag signal had mobility consistent with mature capsid, but it was a larger smeared band in the presence of the inhibitor. (C) Supernatants from 293T cells transfected with Anx2 alone or with HIV-1YU2 and Anx2 were precleared with Protein G agarose beads before incubation with HIV-Ig to bind either intact virions or virions lysed in 0.5% Triton-X-100. Western blot analysis of immunoprecipitated proteins demonstrates that Anx2 was present with mature capsid (p24Gag) in intact virions. Lysing the virions prevented the co-immunoprecipitation of capsid and Anx2, indicating the Anx2-Gag interaction is lost in the mature virion. (D) 293T cells were cotransfected with plasmids encoding HIV-1YU2 and Anx2. Thirty-six hours later, cells were subjected to membrane flotation ultracentrifugation in the presence of 1% Triton X-100 as described in materials and methods. Fractions were combined, concentrated, and analyzed by SDS-PAGE and western blot against Gag, Anx2, the non-raft-associated membrane protein Transferrin receptor (TFR), and the raft-associated membrane protein Flotillin-1 (Flot-1). Detergent resistant membranes floated to fractions 2-5 while cytosol and detergent sensitive membrane remained in fractions 9-12. Anx2 and Gag were present in the lipid raft domains.
###end p 15
###begin p 16
###xml 338 342 338 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-PelchenMatthews1">[49]</xref>
###xml 344 348 344 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Raposo1">[50]</xref>
###xml 398 401 398 401 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 590 596 590 596 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig 1B</bold>
###xml 590 596 590 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g001"><bold>Fig 1B</bold></xref>
###xml 680 683 680 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 215 220 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 393 396 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
As an initial step in determining the site of interaction, we first examined whether Anx2 was present in released virions. Chertova et al. (2006) recently reported that Anx2 is incorporated into virions produced by HIV-1 infected MDMs, evidence that in these cells viral assembly occurs at membranes on which this protein is concentrated [49], [50]. To confirm this finding, supernatants from HIV-1YU2-infected MDMs were filtered through 0.45 um filters to remove cells, and viral particles were precipitated by ultracentrifugation before analysis by SDS-PAGE and western blot. As shown in Fig 1B, the pellets from infected macrophages contained Anx2 as well as mature capsid (p24Gag), confirming that Anx2 was indeed incorporated into virions. The cellular release of microvesicles containing Anx2 was an unlikely alternative explanation, as the pellets from uninfected MDMs contained no Anx2. The absence of cellular debris in the pellets was confirmed by the absence of GAPDH.
###end p 16
###begin p 17
###xml 160 163 160 163 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 179 182 179 182 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 378 381 378 381 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 400 407 400 407 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1B</bold>
###xml 400 407 400 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g001"><bold>Fig. 1B</bold></xref>
###xml 155 158 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 174 177 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 373 376 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
We next determined whether in 293T cells Anx2 was also present at the site of viral assembly. Virions in the supernatants of 293T cells cotransfected with HIV-1YU2 and Anx2, HIV-1YU2 and empty vector, or Anx2 alone were pelleted in the same way as the MDM virions. Anx2 was present in virions from 293T cells overexpressing the protein, but not in cells cotransfected with HIV-1YU2 and empty vector (Fig. 1B). To determine whether the extent of Gag processing influenced Anx2 incorporation, we also analyzed virion-like particles released from cells treated with the protease inhibitor indinavir sulfate (Ind) and in multiple repetitions of the experiment we did not observe significant differences in the extent of Anx2 incorporation. Anx2 was not present in pellets from 293T cells transfected with Anx2 alone, and GAPDH was absent from all pellets, again indicating that cellular microvesicles or secreted Anx2 were an unlikely source of the Anx2 in the pellets.
###end p 17
###begin p 18
###xml 124 145 115 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 343 346 334 337 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 371 372 362 363 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 372 379 363 370 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1C</bold>
###xml 372 379 363 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g001"><bold>Fig. 1C</bold></xref>
###xml 379 380 370 371 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 682 683 673 674 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 683 690 674 681 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1C</bold>
###xml 683 690 674 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g001"><bold>Fig. 1C</bold></xref>
###xml 690 691 681 682 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 42 47 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 102 105 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 338 341 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 442 445 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 975 980 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1021 1026 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To confirm the direct association between HIV-1 virions and Anx2, we immunoprecipitated virions using HIV-IGtrade mark (see Materials and Methods) and analyzed precipitated virions for the presence of Anx2 by SDS-PAGE and western blot. Virus precipitated in the absence of detergent from the supernatants of 293T cells cotransfected with HIV-1YU2 and Anx2 contained Anx2 (Fig. 1C); the presence of Anx2 was not due to non-specific binding of HIV-IG to Anx2, as Anx2 was not brought down with this procedure from supernatants of 293T cells transfected with Anx2 alone. Interestingly, Anx2 was not pulled down when virions were lysed in 0.5% Triton X-100 prior to immunoprecipitation (Fig. 1C), suggesting that while Anx2 initially binds Gag and is incorporated into virions during the process of viral assembly, the Gag-Anx2 association is lost within the infectious virion, perhaps due to the processing of full-length Gag. These data confirm that Anx2 was incorporated into HIV-1 released from 293T cells, as it is from HIV-1 released from macrophages, and thus provide evidence that Anx2 was present at the site of viral assembly in these cells.
###end p 18
###begin title 19
Anx2 and Gag were both present in detergent-resistant membrane fractions of 293T cells
###end title 19
###begin p 20
###xml 126 130 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Lindwasser1">[15]</xref>
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ono1">[19]</xref>
###xml 138 142 138 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ono3">[24]</xref>
###xml 144 148 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Nguyen2">[47]</xref>
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Brugger1">[61]</xref>
###xml 241 244 241 244 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 413 417 413 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ono1">[19]</xref>
###xml 419 423 419 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ono4">[62]</xref>
###xml 424 428 424 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Spearman1">[64]</xref>
###xml 856 860 844 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Brown2">[42]</xref>
###xml 1128 1129 1116 1117 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 1129 1136 1117 1124 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1D</bold>
###xml 1129 1136 1117 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g001"><bold>Fig. 1D</bold></xref>
###xml 1136 1137 1124 1125 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 1445 1449 1433 1437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Adamson1">[11]</xref>
###xml 28 33 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 236 239 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Gag preferentially mediates HIV-1 assembly and budding from detergent-resistant, cholesterol-rich lipid raft membrane domains [15], [19], [24], [47], [61]. To determine whether Gag and Anx2 are both present in these membrane domains in HIV-1YU2 and Anx2 cotransfected 293T cells, we performed membrane flotation ultracentrifugation using a protocol previously employed to study the extent of Gag-membrane binding [19], [62]-[64]. Thirty-six hours after transfection, cells were lysed in buffer containing 1% Triton X-100, adjusted to 73% sucrose, overlayed with 65% and 10% sucrose solutions, and spun at 100,000xg for 20 hrs at 4degreesC. Twelve fractions were collected from the top of the gradient, combined in pairs, and concentrated before analysis by SDS-PAGE and western blot. As lipid rafts by definition are insoluble in Triton-X-100 at 4degreesC [42], these microdomains and associated proteins, such as Flotillin-1 (Flot-1), floated and were over-represented in fractions 2-5, while proteins associated with the cytoplasm or detergent-soluble membranes, such as Transferrin Receptor (TFR), remained in fractions 9-12 (Fig. 1D). Both Gag and Anx2 were present in fractions 3-4, indicating a proportion of both proteins localized to detergent resistant lipid raft microdomains. The increased prevalence of p55 relative to capsid (p24) in these domains is consistent with processed capsid being released from membrane-bound matrix (p17) [11].
###end p 20
###begin title 21
Bimolecular fluorescence complementation revealed that Gag and Anx2 interacted at the plasma membrane of 293T cells
###end title 21
###begin p 22
###xml 909 913 909 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Kerppola1">[65]</xref>
###xml 1230 1234 1230 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Kerppola1">[65]</xref>
###xml 1236 1240 1236 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Nyfeler1">[66]</xref>
###xml 1318 1322 1318 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Boyko1">[67]</xref>
###xml 1324 1328 1324 1328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Jin1">[68]</xref>
###xml 1277 1280 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
To determine whether Gag and Anx2 interacted at lipid rafts, we attempted to co-immunoprecipitate Gag and Anx2 from the detergent-resistant membrane fractions but were unsuccessful, perhaps because of the relatively low protein concentrations. We thus tested our hypothesis that Gag and Anx2 interacted at lipid rafts using bimolecular fluorescence complementation (BiFC), a technique used to study protein-protein interactions in which individually inactive fragments of yellow fluorescent protein (YFP) are fused to proteins of interest. Binding of the fusion proteins when coexpressed in cells brings the YFP fragments in close proximity, allows them to fold together, and results in the formation of a fluorescing complex. Because BiFC does not require cell lysis or antibody staining, it enables the visualization of protein-protein interactions in living cells in their proper intracellular environment [65]. Furthermore, only the fraction of the expressed protein taking part in the interaction is visible, making the determination of the intracellular site of binding more precise. This technique has been used to study, in particular, membrane-associated protein complexes for which the presence of membrane is essential [65], [66] and has recently been used to study HIV Gag interactions and Gag trafficking [67], [68].
###end p 22
###begin p 23
###xml 93 97 93 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Rety1">[69]</xref>
###xml 353 360 353 360 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2A</bold>
###xml 353 360 353 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g002"><bold>Fig. 2A</bold></xref>
###xml 360 361 360 361 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 606 607 606 607 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 607 614 607 614 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2B</bold>
###xml 607 614 607 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g002"><bold>Fig. 2B</bold></xref>
###xml 614 615 614 615 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 780 781 780 781 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 781 788 781 788 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2B</bold>
###xml 781 788 781 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g002"><bold>Fig. 2B</bold></xref>
###xml 788 789 788 789 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 940 941 940 941 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 941 948 941 948 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2C</bold>
###xml 941 948 941 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g002"><bold>Fig. 2C</bold></xref>
###xml 948 949 948 949 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
We used the well-characterized interaction between Anx2 and its cellular binding partner p11 [69] to develop the BiFC assay. YFP-fragment fusion proteins were created with Anx2 fused to fragment 1 of YFP at either the C-terminus (Anx2C-FR1) or N-terminus (Anx2N-FR1) of the construct. Binding partner p11 was also fused to fragment 2 of YFP (p11N-FR2) (Fig. 2A). Thirty-six hours after transfection with the Anx2 and/or p11 BiFC constructs, 293T cells were fixed, stained with DAPI, and visualized by confocal microscopy. Expression of either Anx2C-YFP1 or p11N-YFP2 alone did not produce YFP fluorescence (Fig. 2B). Furthermore, cotransfection of constructs expressing the two YFP fragments unlinked to a protein of interest (YFP-1 and YFP-2) also failed to produce fluorescence (Fig. 2B). Cotransfection of Anx2C-YFP1 with p11N-YFP2, however, resulted in fluorescence complementation, indicating a direct interaction between Anx2 and p11 (Fig. 2C).
###end p 23
###begin title 24
###xml 72 75 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
Bimolecular fluorescence complementation (BiFC) showed that Anx2 and p41Gag interacted at the plasma membrane of 293T cells.
###end title 24
###begin p 25
###xml 659 662 659 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 745 748 745 748 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 843 846 843 846 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 932 935 932 935 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 1018 1021 1018 1021 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 1116 1119 1116 1119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
293T cells transfected with the indicated constructs were stained with DAPI and visualized by confocal microscopy 36 hours post-transfection. (A) BiFC constructs. N and C in the designation denote location at the N- or C-terminus of the construct, respectively. Gly: Glycine linker (not to scale). (B) No YFP fluorescence was detected in 293T cells transfected with single constructs or in cells cotransfected with both YFP fragments. (C) YFP fluorescence, indicating an interaction between p11 and Anx2, was detected in 293T cells cotransfected with p11 and Anx2 BiFC constructs (positive control). (D) YFP fluorescence, indicating an interaction between p41Gag and Anx2, was detected at the plasma membrane of 293T cells cotransfected with p41Gag and Anx2 BiFC constructs. (E) No YFP fluorescence was detected in cells cotransfected with p41Gag and CD63 BiFC constructs (left panel), despite colocalized expression of CD63 and p41Gag as demonstrated by immunolabeling (right panel). These data indicated CD63 and p41Gag did not interact and confirmed the specificity of the fluorescence complementation between p41Gag and Anx2.
###end p 25
###begin p 26
###xml 165 168 165 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 170 171 170 171 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 171 178 171 178 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2A</bold>
###xml 171 178 171 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g002"><bold>Fig. 2A</bold></xref>
###xml 178 179 178 179 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 202 205 202 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 276 283 276 283 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2D</bold>
###xml 276 283 276 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g002"><bold>Fig. 2D</bold></xref>
###xml 564 567 564 567 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 651 654 651 654 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 964 967 964 967 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 998 999 998 999 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 999 1006 999 1006 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2D</bold>
###xml 999 1006 999 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g002"><bold>Fig. 2D</bold></xref>
###xml 1006 1007 1006 1007 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 1037 1040 1037 1040 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 1140 1144 1140 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Finzi2">[70]</xref>
###xml 1145 1149 1145 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Rudner1">[73]</xref>
We then created two constructs with Gag fused to fragment 2 of YFP, one encoding full-length Gag and another encoding the N-terminal matrix-capsid region of Gag (p41Gag) (Fig. 2A). Cotransfection of p41Gag and Anx2C resulted in fluorescence complementation as demonstrated in Fig. 2D. There was no difference in signal intensity or localization when Anx2N was used instead of Anx2C, and Anx2C was therefore used for all further experiments. While both Gag constructs produced fluorescence complementation when cotransfected with Anx2, the signal resulting from p41Gag was greater than that from full-length Gag (not shown). Complementation between p41Gag and Anx2C indicated that the Anx2 binding site on Gag is located in the matrix and/or capsid regions, and the reduced fluorescence observed with full-length Gag is likely due to the greater distance between YFP fragments in the Anx2-Gag complex. The YFP fluorescence was detected at the plasma membrane of p41Gag and Anx2C cotransfected cells (Fig. 2D), indicating that the Anx2-p41Gag interaction occurred at the plasma membrane, the site of virion assembly and budding in 293T cells [70]-[73]. There was no signal attributable to binding within intracellular organelles or vacuoles.
###end p 26
###begin p 27
###xml 69 72 69 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 227 228 227 228 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 228 235 228 235 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2A</bold>
###xml 228 235 228 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g002"><bold>Fig. 2A</bold></xref>
###xml 235 236 235 236 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 385 389 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Sato1">[74]</xref>
###xml 499 502 499 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 685 686 685 686 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 686 693 686 693 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2E</bold>
###xml 686 693 686 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g002"><bold>Fig. 2E</bold></xref>
###xml 693 694 693 694 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 749 752 749 752 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 370 375 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
To ensure that the fluorescence complementation between Anx2C and p41Gag represented a direct interaction between the two proteins and not mere close proximity, we prepared a CD63-YFP fragment 1 construct as a negative control (Fig. 2A). In 293T cells, CD63 is expressed at the plasma membrane in addition to intracellular compartments and is incorporated into released HIV-1 virions [[74] and data not shown)] and is therefore present near the site of viral assembly. Cotransfection of CD63 and p41Gag produced no fluorescence despite expression of both CD63 and p41 in similar regions of the cell as indicated by immunolabeling of the proteins and examination by confocal microscopy (Fig. 2E). This result confirmed the specificity of the Anx2-p41Gag interaction.
###end p 27
###begin title 28
Anx2 and Gag interacted at GM1-containing lipid rafts in the plasma membrane of 293T cells
###end title 28
###begin p 29
###xml 81 85 81 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Liao1">[16]</xref>
###xml 86 90 86 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ono1">[19]</xref>
###xml 120 123 120 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 367 371 365 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Eidels1">[75]</xref>
###xml 373 377 371 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ilangumaran1">[76]</xref>
###xml 510 514 508 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Harder2">[77]</xref>
###xml 651 654 649 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 736 737 734 735 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 737 743 735 741 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3</bold>
###xml 737 743 735 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g003"><bold>Fig. 3</bold></xref>
###xml 743 744 741 742 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 preferentially assembles at and buds from lipid raft membrane microdomains [16]-[19]. To determine whether the p41Gag-Anx2 interaction occurred at these regions of the plasma membrane, 293T cells transfected with the BiFC constructs were incubated with Alexa Fluor(R) 594-conjugated cholera toxin B (CTB), which binds to the raft component ganglioside M1 (GM1) [75], [76]. The CTB-labeled rafts were then crosslinked with anti-CTB antibody in order to create distinct raft patches on the plasma membrane [77] and visualized by confocal microscopy. YFP fluorescence colocated with the GM1-containing membrane patches, indicating that the Anx2-p41Gag interaction occurred on GM1-containing lipid raft regions of the plasma membrane (Fig. 3) and providing further support that Gag and Anx2 interact at the site of virion assembly and budding.
###end p 29
###begin title 30
Anx2 and Gag interacted at GM-1-containing lipid rafts in the plasma membrane of 293T cells.
###end title 30
###begin p 31
###xml 33 36 33 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 333 336 331 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
293T cells cotransfected with p41Gag and Anx2 BiFC constructs were fixed and incubated with Alexa Fluor(R) 594 conjugated cholera toxin B (CTB) to label the lipid raft component ganglioside M1 (GM1) followed by crosslinking of the raft regions with anti-CTB antibody. YFP colocalized with CTB-containing patching, indicating that p41Gag and Anx2 interacted at GM1-containing lipid rafts.
###end p 31
###begin title 32
###xml 95 96 95 96 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The Anx2-Gag interaction was dependent on the intracellular location and levels of PtdIns(4,5)P2
###end title 32
###begin p 33
###xml 63 64 63 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 149 153 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Saad1">[21]</xref>
###xml 251 252 251 252 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 302 303 302 303 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 387 391 387 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ono2">[20]</xref>
###xml 418 419 418 419 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 543 547 543 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ono2">[20]</xref>
###xml 583 584 583 584 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 609 613 609 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ono2">[20]</xref>
Along with lipid raft components, the phospholipid PtdIns(4,5)P2, plays an important role in the targeting and binding of Gag to the plasma membrane [21]. Whereas in normal HeLa cells Gag is directed to the plasma membrane, redirection of PtdIns(4,5)P2 from the plasma membrane to internal PtdIns(4,5)P2-rich endosomal structures also redirects Gag and viral budding to these structures [20]. Depletion of PtdIns(4,5)P2 altogether also causes failure of Gag trafficking to the plasma membrane and instead accumulation of Gag in late endosomes [20]. Both manipulations of PtdIns(4,5)P2 reduce viral production [20].
###end p 33
###begin p 34
###xml 70 71 70 71 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 166 167 166 167 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 272 275 272 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 397 398 397 398 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 508 516 504 508 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLC&#948;</sub>
###xml 565 566 557 558 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 566 570 558 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Varnai1">[78]</xref>
###xml 614 622 606 610 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLC&#948;</sub>
###xml 697 698 685 686 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 698 705 686 693 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4A</bold>
###xml 698 705 686 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g004"><bold>Fig. 4A</bold></xref>
###xml 705 706 693 694 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 706 710 694 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ono2">[20]</xref>
###xml 712 716 700 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Varnai1">[78]</xref>
###xml 746 747 734 735 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 814 822 802 806 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLC&#948;</sub>
###xml 977 978 961 962 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1009 1013 993 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Aikawa1">[79]</xref>
###xml 1015 1019 999 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Brown3">[80]</xref>
###xml 1033 1037 1017 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ono2">[20]</xref>
###xml 1047 1051 1031 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Hayes1">[81]</xref>
###xml 1101 1109 1085 1089 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLC&#948;</sub>
###xml 1246 1247 1226 1227 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1247 1248 1227 1228 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 1248 1255 1228 1235 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4B</bold>
###xml 1248 1255 1228 1235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g004"><bold>Fig. 4B</bold></xref>
###xml 1255 1256 1235 1236 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 1409 1410 1389 1390 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1410 1414 1390 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Kisseleva1">[82]</xref>
###xml 1506 1507 1486 1487 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1533 1534 1513 1514 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 1534 1541 1514 1521 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4C</bold>
###xml 1534 1541 1514 1521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g004"><bold>Fig. 4C</bold></xref>
###xml 1541 1542 1521 1522 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 1599 1603 1579 1583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ono2">[20]</xref>
To determine whether the Anx2-Gag interaction occurred on PtdIns(4,5)P2-containing membrane domains, we altered the levels and intracellular locations of PtdIns(4,5)P2 and investigated the effects of these manipulations on fluorescence complementation between Anx2 and p41Gag. The results described below were the predominant effects observed in multiple fields of cells. To visualize PtdIns(4,5)P2, we used a construct expressing GFP fused to the pleckstrin homology (PH) domain of phospholipase C-delta (PHPLCdelta-GFP) that has been shown to bind to PtdIns(4,5)P2[78]. When transfected alone into 293T cells, PHPLCdelta-GFP localized primarily to the plasma membrane as previously demonstrated (Fig. 4A)[20], [78]. To redistribute PtdIns(4,5)P2 away from the plasma membrane, we cotransfected 293T cells with PHPLCdelta-GFP and HA-tagged ADP-ribosylation factor 6/Q67L (Arf6/Q67L), a constitutively active form of Arf6 which causes intracellular accumulation of PtdIns(4,5)P2-enriched endosomal structures [79], [80] to which Gag [20] and Anx2 [81] are directed. Cotransfection of Arf6/Q67L with PHPLCdelta-GFP redistributed GFP expression away from the plasma membrane and into intracellular formations, indicating redirection of PtdIns(4,5)P2(Fig. 4B). When co-transfected with myc-tagged phosphoinositide-specific inositol polyphosphate 5-phosphatase IV (5ptase IV), an enzyme that depletes PtdIns(4,5)P2[82], GFP became diffusely distributed throughout the cell, indicating depletion of PtdIns(4,5)P2 from the plasma membrane (Fig. 4C); this effect has been previously observed in HeLa cells [20].
###end p 34
###begin title 35
###xml 12 15 12 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 52 53 52 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 132 133 132 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The Anx2-p41Gag interaction occurred at PtdIns(4,5)P2-enriched membrane domains and depended on intracellular levels of PtdIns(4,5)P2.
###end title 35
###begin p 36
###xml 200 208 200 204 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLC&#948;</sub>
###xml 233 234 229 230 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 310 311 306 307 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 323 331 319 323 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLC&#948;</sub>
###xml 491 492 483 484 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 506 514 498 502 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLC&#948;</sub>
###xml 722 723 710 711 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 748 751 736 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 863 864 851 852 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 893 896 881 884 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 939 940 927 928 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1066 1069 1054 1057 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 1176 1179 1164 1167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 1205 1208 1193 1196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 1259 1262 1247 1250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
293T cells transfected with the indicated constructs were immunostained for protein (p41) or tag (HA, c-myc), labeled with DAPI and visualized by confocal microscopy 36 hours post-transfection. (A) PHPLCdelta-GFP labeled PtdIns(4,5)P2 at the plasma membrane of 293T cells. (B) Arf6/Q67L redirected PtdIns(4,5)P2 and thus PHPLCdelta-GFP to intracellular membranes. Cells expressing Arf6/Q67L were identified by immunolabeling for the HA tag (middle panel). (C) 5ptase IV depletes PtdIns(4,5)P2 and causes PHPLCdelta-GFP to be diffusely distributed throughout the cytoplasm and nucleus. Cells expressing 5ptase IV were identified by immunolabeling for the c-myc tag (middle panel). (D) In 293T cells with normal PtdIns(4,5)P2 expression, the Anx2-p41Gag interaction, as denoted by YFP fluorescence complementation, occurred at the plasma membrane where PtdIns(4,5)P2 is located. (E) The Anx2-p41Gag interaction was redirected to PtdIns(4,5)P2 -enriched intracellular membranes when 293T cells expressed Arf6/Q67L. (F) Depletion of with 5ptase IV inhibited the Anx2-p41Gag interaction as indicated by reduced YFP fluorescence complementation. Reduced binding between Anx2 and p41Gag is not due to reduced p41Gag expression, as determined by immunolabeling of p41Gag (middle panel).
###end p 36
###begin p 37
###xml 64 65 64 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 94 97 94 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 161 164 161 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 315 316 315 316 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 316 323 316 323 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4D</bold>
###xml 316 323 316 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g004"><bold>Fig. 4D</bold></xref>
###xml 323 324 323 324 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 521 522 521 522 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 555 556 555 556 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 556 563 556 563 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4E</bold>
###xml 556 563 556 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g004"><bold>Fig. 4E</bold></xref>
###xml 563 564 563 564 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 583 586 583 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 693 694 693 694 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 746 747 746 747 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 747 754 747 754 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4F</bold>
###xml 747 754 747 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g004"><bold>Fig. 4F</bold></xref>
###xml 754 755 754 755 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 830 833 830 833 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 937 938 937 938 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 938 949 938 949 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figs. 4D, F</bold>
###xml 938 949 938 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g004"><bold>Figs. 4D, F</bold></xref>
###xml 949 964 949 964 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> middle panels)</bold>
###xml 1065 1066 1065 1066 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1129 1130 1129 1130 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
We next tested the effect of these manipulations of PtdIns(4,5)P2 on BiFC between Anx2 and p41Gag in 293T cells. As described above, transfection of Anx2 and p41Gag resulted in YFP fluorescence at the plasma membrane, indicating that the site of viral assembly is the site of interaction between these two proteins (Fig. 4D). Cotransfection of the BiFC constructs with Arf6/Q67L redirected YFP from the plasma membrane to intracellular compartments, indicating that the Anx2-Gag complex was redirected to the PtdIns(4,5)P2-containing endosomal structures (Fig. 4E). When Anx2 and p41Gag were cotransfected with 5ptase IV, YFP was no longer detected, indicating that the absence of PtdIns(4,5)P2 inhibited the interaction between the two proteins (Fig. 4F). This failure of fluorescence complementation is despite expression of p41Gag that was comparable to cells in which 5ptase IV is not expressed as indicated by immunolabeling of Gag (Figs. 4D, F middle panels). These data indicated not only that the Anx2-Gag interaction occurred preferentially on PtdIns(4,5)P2-enriched membranes, but also that the presence of PtdIns(4,5)P2 was necessary for this interaction to occur efficiently.
###end p 37
###begin p 38
###xml 78 79 78 79 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 509 512 509 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ryzhova1">[9]</xref>
###xml 647 650 647 650 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 694 697 694 697 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 197 202 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 642 645 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 689 692 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Our experiments demonstrating that Gag and Anx2 interacted at the PtdIns(4,5)P2 enriched lipid raft membrane domains at which viral assembly occurs in 293T cells support a role for this protein in HIV-1 assembly and budding. A functional role for Anx2 was also suggested by our previous loss-of-function studies showing that siRNA-mediated downregulation of Anx2 in macrophages led to decreased viral replication, aberrant Gag processing, and failure of mature virions to accumulate in intracellular vesicles [9]. To identify a gain-of-function role for Anx2, we compared Gag processing and viral production in 293T cells co-transfected with HIV-1YU2 and Anx2 to those co-transfected with HIV-1YU2 and empty vector.
###end p 38
###begin title 39
###xml 51 56 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Anx2 gain-of-function increased Gag processing and HIV-1 production in 293T cells
###end title 39
###begin p 40
###xml 131 134 131 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 433 434 430 431 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 434 441 431 438 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5A</bold>
###xml 434 441 431 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g005"><bold>Fig. 5A</bold></xref>
###xml 441 442 438 439 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 829 830 823 824 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 830 837 824 831 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5B</bold>
###xml 830 837 824 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g005"><bold>Fig. 5B</bold></xref>
###xml 837 838 831 832 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 872 875 866 869 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 974 975 968 969 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 975 982 969 976 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5C</bold>
###xml 975 982 969 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g005"><bold>Fig. 5C</bold></xref>
###xml 982 984 976 978 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">).</bold>
###xml 1207 1210 1201 1204 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 1241 1244 1235 1238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 1308 1311 1302 1305 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 1399 1406 1393 1400 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5D</bold>
###xml 1399 1406 1393 1400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g005"><bold>Fig. 5D</bold></xref>
###xml 387 390 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1202 1205 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
We noted that in many co-transfection experiments Anx2 expression appeared to enhance the processing of Gag into mature capsid (p24Gag), an event associated with maturation of assembled virions. To quantify this effect, we analyzed cell lysates from three independent transfections in which this enhancement was seen. Lysates were subjected to SDS-PAGE followed by western blotting with HIV Immunoglobulin and antibody to beta-actin (Fig. 5A). When normalized to beta-actin levels, Anx2 increased total Gag levels in each transfection, but when averaged over all 3 experiments the increase was not statistically significant (p = 0.096) However, Anx2 did increase the percent of total Gag that was processed into mature capsid (p24) from an average of 26.8% to 43.6%, an effect that was highly statistically significant (p<0.002) (Fig. 5B). Measurement of intracellular p24Gag concentration in these lysates by ELISA confirmed that Anx2 increased intracellular capsid levels (Fig. 5C). The increase in Gag processing was not observed in every transfection, so to better quantify the overall effects of Anx2 on intracellular capsid levels, lysates from 19 independent co-transfections of 293T cells with HIV-1YU2 and Anx2 were analyzed for p24Gag concentration using ELISA. Anx2 increased the intracellular p24Gag concentration in 15/19 experiments; the average increase of all experiments was 90.2% (Fig. 5D).
###end p 40
###begin title 41
Anx2 gain-of-function in 293T cells increased Gag processing and viral production.
###end title 41
###begin p 42
###xml 44 47 44 47 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 314 317 311 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 341 344 338 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 484 487 481 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 608 611 605 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 828 831 825 828 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 893 896 890 893 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 1004 1007 1001 1004 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 1042 1045 1039 1042 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 39 42 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 242 245 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 823 826 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 999 1002 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1037 1040 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
(A) 293T cells were cotransfected with HIV-1YU2 and either empty vector or Anx2. At 36-48 hrs after transfection, the cells were lysed in 0.5% Triton-X. Lysates from 3 independent transfections were analyzed by SDS-PAGE and western blot with HIV-Ig, anti-Anx2, and anti-beta-actin. Anx2 increased processing of p55Gag into mature capsid (p24Gag). (B) Quantification of the western blot in (A) with NIH Image J. Anx2 increased the percent of total Gag processed into mature capsid (p24Gag) (p<0.002) using a correlated samples two-tailed student's t-test. Error bars represent standard deviations. (C) The p24Gag concentration of the lysates shown in (A) was determined by ELISA. Anx2 increased the mature capsid concentration as suggested by the western blot analysis in (A). (D) Lysates from 19 different transfections of HIV-1YU2 with either empty vector or Anx2 were prepared as in (A). p24Gag concentrations of the lysates were determined by ELISA. The average ratio of the experimental values (HIV-1YU2+Anx 2) to the control value (HIV-1YU2+vector) are shown on the bar graph. The error bars represent standard errors of the means. Statistical analysis was performed using paired two-tail student's t test. Anx2 increased the intracellular concentration of mature capsid.
###end p 42
###begin p 43
###xml 140 143 140 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ryzhova1">[9]</xref>
###xml 277 280 277 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 370 373 370 373 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 488 491 488 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 545 552 545 552 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6A</bold>
###xml 545 552 545 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g006"><bold>Fig. 6A</bold></xref>
###xml 1130 1134 1130 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Derdeyn1">[83]</xref>
###xml 1135 1139 1135 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Wei1">[85]</xref>
###xml 1148 1151 1148 1151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 1232 1239 1232 1239 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6B</bold>
###xml 1232 1239 1232 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g006"><bold>Fig. 6B</bold></xref>
###xml 1538 1539 1538 1539 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 1539 1546 1539 1546 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6C</bold>
###xml 1539 1546 1539 1546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g006"><bold>Fig. 6C</bold></xref>
###xml 1546 1547 1546 1547 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 46 51 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 365 368 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1049 1054 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1688 1693 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1926 1931 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In previous experiments, depletion of Anx2 in HIV-1 infected macrophages not only impaired Gag processing but also reduced virus production [9]. To determine whether Anx2 expression in 293T cells could have the opposite effect (i.e. increased viral production), we measured p24Gag concentration in the supernatants of the cells from 47 separate co-transfections of HIV-1YU2 with either Anx2 or empty vector at 36 hr post-transfection. Anx2 overexpression was associated with increased p24Gag release into the supernatant by an average of 68.8% (Fig. 6A). As with Gag processing, however, there was experimental variability in the effects of Anx2 on viral production, likely due to differences in transfection efficiency and cell density between transfections. To ensure that the Anx2-mediated increase in mature capsid represented an increase in the production of infectious virus, supernatants from three independent transfections demonstrating this increase were used to infect TZM-bl cells, which express the luciferase gene under control of the HIV-1 promoter and which have been used previously to quantify virus infectivity [83]-[85]. The p24Gag concentrations in cell supernatants from these three transfections are shown in Fig. 6B; Anx2 significantly increased the concentration of mature capsid in each transfection. To quantify infectious virus, equal volumes of these supernatants were applied to TZM-bl cells for 24 hours. The amount of infected cells in each condition was then quantified by analyzing luciferase expression (Fig. 6C). Consistent with the measured mature capsid concentrations, supernatants from cells expressing Anx2 contained significantly more infectious HIV-1 than control cells in each of the three transfections. These data indicated Anx2 gain-of-function in 293T cells led to enhanced Gag processing and increased infectious viral production and thus support a functional role for Anx2 in HIV-1 assembly and budding.
###end p 43
###begin title 44
###xml 75 80 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Anx2 gain-of-function in 293T cells increased the production of infectious HIV-1.
###end title 44
###begin p 45
###xml 44 47 44 47 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 157 160 157 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 254 257 254 257 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 293 296 293 296 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 522 525 522 525 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 559 562 559 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 666 669 666 669 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 685 688 685 688 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 39 42 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 249 252 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 288 291 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 517 520 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 661 664 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 680 683 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1038 1043 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
(A) 293T cells were cotransfected with HIV-1YU2 and either empty vector or Anx2. At 36-48 hrs after transfection, the supernatants were collected and the p24Gag concentrations were determined by ELISA. The average ratios of the experimental values (HIV-1YU2+Anx 2) to the control values (HIV-1YU2+vector) are shown on the bar graph. Data represent 46 different transfections; error bars represent standard errors of the means. Statistical analysis was performed using paired two-tail student's t test. Anx2 increased HIV-1YU2 production by 293T cells. (B) p24Gag concentrations in the supernatants from three independent transfections of 293T cells with either HIV-1YU2+Vector or HIV-1YU2+Anx2 were measured by ELISA. Anx2 increased viral production in each transfection. Error bars represent standard deviations. Statistical analysis was performed using unpaired two-tail student's t test. (C) Quantification of infectious virus in the supernatants shown in (B) using TZM-bl cells expressing the luciferase gene under the control of the HIV-1 promoter. TZM-bl were infected with equal volumes of supernatants from both control and Anx2-expressing 293T cells and luciferase expression in relative light units (RLU) was determined after 24 hours and taken as a measure of the amount of infectious virus present. More infectious virus was present in the supernatants of Anx2-expressing 293T cells in comparison with control cells in each of the three transfections. Error bars represent standard deviations. Statistical analysis was performed using unpaired two-tail student's t test.
###end p 45
###begin title 46
Discussion
###end title 46
###begin p 47
###xml 450 454 450 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Lindwasser1">[15]</xref>
###xml 456 460 456 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Nguyen1">[18]</xref>
###xml 462 466 462 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ono1">[19]</xref>
###xml 468 472 468 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Finzi2">[70]</xref>
###xml 473 477 473 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Rudner1">[73]</xref>
###xml 563 564 563 564 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 667 671 667 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Saad1">[21]</xref>
###xml 672 676 672 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Freed1">[23]</xref>
###xml 678 682 678 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ono6">[86]</xref>
###xml 711 712 711 712 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 792 796 792 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ono6">[86]</xref>
###xml 1342 1345 1342 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ryzhova1">[9]</xref>
###xml 59 64 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 421 424 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 873 878 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Here we present further evidence that Anx2 plays a role in HIV-1 assembly and budding by characterizing the intracellular site of the Anx2-Gag interaction and by investigating the effects of Anx2 gain-of-function on viral replication in 293T cells. Bimolecular fluorescence complementation demonstrated that Anx2 and Gag interacted at GM1-containing lipid rafts in the plasma membrane, the membrane microdomains at which HIV assembles in these cells [15], [18], [19], [70]-[73]. Efficient formation of the Anx2-Gag complex depended on the presence of PtdIns(4,5)P2, a membrane phospholipid that targets Gag to the plasma membrane and facilitates Gag-membrane binding [21]-[23], [86]. Redirection of PtdIns(4,5)P2 to intracellular membranes - a manipulation that also redirects viral assembly [86] - also redirected the complex to the cytoplasm. The presence of Anx2 at the HIV-1 assembly site was confirmed in the context of whole virus replication in 293T cells, as Anx2 was present with Gag in detergent-resistant membrane fractions containing lipid rafts and in the released virions. Finally, Anx2 gain-of-function in 293T cells led to enhanced Gag processing and increased viral production, findings that complement our previous studies showing that knockdown of Anx2 in MDMs led to impaired Gag processing and decreased viral production [9].
###end p 47
###begin p 48
###xml 165 166 165 166 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 247 251 247 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Liao1">[16]</xref>
###xml 252 256 252 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Saad1">[21]</xref>
###xml 350 351 350 351 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 479 483 479 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Saad1">[21]</xref>
###xml 533 537 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ono4">[62]</xref>
###xml 539 543 539 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Spearman1">[64]</xref>
###xml 545 549 545 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Paillart1">[87]</xref>
###xml 551 555 551 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Tang1">[88]</xref>
###xml 566 574 566 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 671 672 671 672 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 672 676 672 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Chukkapalli1">[22]</xref>
###xml 838 842 838 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ono1">[19]</xref>
###xml 904 905 904 905 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1061 1065 1061 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Saad1">[21]</xref>
###xml 1067 1071 1067 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Freed1">[23]</xref>
###xml 1234 1238 1234 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ono1">[19]</xref>
###xml 1240 1244 1240 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ono3">[24]</xref>
###xml 1246 1250 1246 1250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ono5">[63]</xref>
###xml 1252 1256 1252 1256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ono7">[89]</xref>
###xml 1258 1262 1258 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Nermut1">[90]</xref>
Based on the known functions of Anx2, we propose that the most likely mechanism behind our results is Anx2-mediated creation and/or stabilization of the PtdIns(4,5)P2-containing lipid raft membrane domains from which the virus preferentially buds [16]-[21]. In this model, Anx2-Gag binding would function to recruit Gag to these domains. PtdIns(4,5)P2 interacts directly with hydrophobic residues in the matrix domain of Gag and triggers exposure of the N-terminal myristic acid [21], an event that is important for membrane-binding [62], [64], [87], [88]. A recent in vitro study confirmed that efficient binding of Gag to liposomes requires the presence of PtdIns(4,5)P2[22]. After initial membrane binding, Gag becomes associated with the highly ordered membrane microdomains rich in sphingolipids and cholesterol known as lipid rafts [19]. This localization may be facilitated by the Gag-PtdIns(4,5)P2 interaction, as the unsaturated 2' side chain of the phospholipids leaves the lipid bilayer to bind matrix, leaving the saturated 1' fatty acid side chain [21], [23]. Other studies have suggested that lipid rafts may serve as platforms that enable the higher order Gag multimerization that occurs after initial membrane binding [19], [24], [63], [89], [90].
###end p 48
###begin p 49
###xml 73 77 73 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Babiychuk1">[39]</xref>
###xml 79 83 79 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-ChasserotGolaz1">[40]</xref>
###xml 133 134 133 134 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 134 138 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Hayes1">[81]</xref>
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Rescher1">[91]</xref>
###xml 196 197 196 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 258 262 258 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Gokhale1">[45]</xref>
###xml 713 717 713 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Khorchid1">[92]</xref>
###xml 1084 1087 1084 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ryzhova1">[9]</xref>
###xml 807 812 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Anx2 can laterally aggregate and stabilize cholesterol-rich microdomains [39], [40]. Furthermore, Anx2 binds directly to PtdIns(4,5)P2[81], [91] and can induce the formation of stable PtdIns(4,5)P2 clusters within membranes in a cholesterol-dependent manner [45]. At intracellular membranes in macrophages and at the plasma membrane of 293T cells, Anx2 may thus help to create and/or stabilize domains that enhance initial Gag-membrane binding and facilitate Gag-Gag multimerization and increase viral production. This mechanism would explain increased Gag processing, as enhanced lipid raft-binding and Gag multimerization would in turn facilitate dimerization of Gag-Pol precursors within the assembling virion [92] and thus activation of the viral protease. As noted, siRNA-mediated depletion of Anx2 in HIV-1 infected macrophages not only reduced overall virion production but also induced defects in Gag processing that were associated with reduced infectivity of released virions, effects that we hypothesized resulted from destabilization of lipid rafts in the absence of Anx2 [9].
###end p 49
###begin p 50
###xml 62 63 62 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 180 181 180 181 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 626 630 626 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Orenstein1">[48]</xref>
###xml 631 635 631 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Raposo1">[50]</xref>
###xml 637 641 637 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Finzi2">[70]</xref>
###xml 642 646 642 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Rudner1">[73]</xref>
###xml 648 652 648 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Deneka1">[93]</xref>
###xml 667 670 667 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ryzhova1">[9]</xref>
###xml 921 926 921 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">first</italic>
###xml 1162 1168 1162 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">second</italic>
###xml 1343 1344 1343 1344 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1450 1454 1450 1454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ono2">[20]</xref>
###xml 1499 1500 1499 1500 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1616 1617 1616 1617 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 307 312 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 335 340 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The localization of Anx2-Gag complexes to GM1 and PtdIns(4,5)P2-containing membrane domains, as well as the dependence of the interaction on the levels and location of PtdIns(4,5)P2, are consistent with the scenario in which Anx2-mediated stabilization of such domains is important for Anx2-Gag binding and HIV-1 assembly. Of note, in HIV-1 infected MDMs Anx2 and Gag collocated with CD63 positive internal membranes, in contrast to the plasma membrane localization of the Anx2-Gag BiFC complexes in 293T cells. Importantly, the membranes at which the interaction occurs represent the site of viral assembly in each cell type [48]-[50], [70]-[73], [93]. In both MDMs [9] and transfected 293Ts (not shown), Anx2 expression was diffusely distributed and not confined to areas of collocation with Gag. Our data do not distinguish between the two most likely explanations for the different sites of the Gag-Anx2 interaction: first, that the ability of Anx2 to perform its function in viral assembly is spatially regulated by cell-specific factors in endosomal membranes in MDMs and in the plasma membrane in 293T cells, leading to Gag recruitment to those sites; or second, that Anx2 performs its function throughout each cell but Gag targeting is mediated by another cell-specific molecule or mechanism. Cell-specific distribution of PtdIns(4,5)P2 may be one such mechanism, as its redistribution from the plasma membrane redirected both viral assembly [20] and the Anx2-Gag interaction to PtdIns(4,5)P2-enriched internal membranes. We are currently performing studies to determine the relationship between PtdIns(4,5)P2 localization and Anx2 function in MDMs.
###end p 50
###begin p 51
###xml 454 458 454 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Drust1">[94]</xref>
###xml 459 463 459 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Senda1">[99]</xref>
###xml 606 611 606 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Derry1">[100]</xref>
###xml 613 618 613 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Raynor1">[101]</xref>
###xml 754 759 754 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Filipenko1">[102]</xref>
###xml 761 766 761 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Gerke1">[103]</xref>
###xml 817 822 817 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Hayes2">[104]</xref>
###xml 882 887 882 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Rescher2">[105]</xref>
###xml 1321 1322 1321 1322 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(</bold>
###xml 1322 1330 1322 1330 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figs. 1A</bold>
###xml 1322 1330 1322 1330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g001"><bold>Figs. 1A</bold></xref>
###xml 1330 1332 1330 1332 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, </bold>
###xml 1332 1334 1332 1334 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5A</bold>
###xml 1332 1334 1332 1334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005020-g005"><bold>5A</bold></xref>
###xml 1334 1335 1334 1335 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 514 517 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 563 566 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 669 672 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 916 919 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
There are several other potential, though not mutually exclusive, explanations for the increase in viral production seen with Anx2. For example, binding between Anx2 and Gag could induce conformational changes in Gag, possibly triggering the myristyl switch that enhances Gag-membrane binding. Anx2 can also promote the aggregation and fusion of membrane-bound structures such as secretory granules with the plasma membrane and endosomes with each other [94]-[99]. The latter function is thought to be relevant in CMV infection, as Anx2 can enhance the fusion of CMV with phospholipid-containing membranes [100], [101]. Anx2 might similarly facilitate this process for HIV, which also requires fusion events for budding. Anx2 is an actin-binding protein [102], [103] with the ability to regulate actin polymerization [104] and may act as a membrane-cytoskeletal scaffolding protein [105]. Anx2 could thus facilitate HIV production by mediating Gag-actin interactions and Gag trafficking. Finally, as Anx2 is a multifunctional protein, overexpression could have a general effect on cellular processes and only indirectly increase viral assembly. Cotransfection of Anx2, however, did not produce evident structural abnormalities by EM (data not shown) or change the expression of cellular proteins such as GAPDH or B-actin (Figs. 1A, 5A), arguing for a relatively specific effect of Anx2.
###end p 51
###begin p 52
###xml 392 397 392 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Wahl1">[106]</xref>
###xml 253 258 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 322 325 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 505 510 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Future experiments will more precisely determine the mechanism by which Anx2 facilitates Gag-mediated assembly, budding, processing and release. Ultimately, we hope to gain sufficient understanding of this mechanism to determine the function of Anx2 in HIV-1 replication in macrophages. As the host proteins that regulate HIV replication are likely to be different in T cells and macrophages [106], such an understanding will be crucial in the eventual development of therapies to counteract the roles of HIV-1 infected macrophages in viral transmission, reservoir formation, and neuropathogenesis.
###end p 52
###begin title 53
Materials and Methods
###end title 53
###begin title 54
Plasmids and cell transfection
###end title 54
###begin p 55
###xml 72 75 72 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 144 152 144 148 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLC&#948;</sub>
###xml 206 210 202 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Varnai1">[78]</xref>
###xml 301 305 297 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Kisseleva1">[82]</xref>
###xml 705 708 701 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 750 753 746 749 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 970 975 966 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Wodrich1">[107]</xref>
###xml 1022 1025 1018 1021 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 67 70 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 455 460 <span type="species:ncbi:9606">human</span>
###xml 461 464 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
We received several plasmids as gifts from other laboratories: the HIV-1YU2 proviral genome (RF-1) from Dr. M. Malim, King's College, London; PHPLCdelta-GFP from Dr. T. Balla, National Institutes of Health [78]; 5ptase IV from Dr. P.W. Majerus, Washington University School of Medicine, St. Louis, MO [82]; and Arf6/Q67L form Dr. J.G. Donaldson, National Institutes of Health. Anx2 was cloned into the pcDNA3.1(+) vector (Invitrogen) under control of the human CMV promoter. For BiFC, the coding sequence for the N-terminal 160 residue fragment of YFP (FR1) along with a linker segment of 12 glycines was cloned into the pcDNA3.1(-) vector attached to either the N- or C-terminus of Anx2. To construct p41Gag-FR2, the matrix and capsid domains of p55Gag were amplified from the codon-optimized pGagEGFP plasmid, a gift from Dr. M. Resh, Memorial Sloan-Kettering Cancer Center. Four constitutive transport elements (CTE; a gift from Dr. M. Malim, King's College, London; [107]) were cloned into the 3'UTR of p41Opt. The p41Gag segment and the C-terminal 82 residues of YFP (FR2) along with a linker segment of 12 glycines were cloned into the pcDNA3.1(-) vector.
###end p 55
###begin p 56
###xml 238 241 238 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 309 312 309 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 126 129 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
293T cells were transfected using the calcium-phosphate method (Promega ProFection kit). For studies of the effect of Anx2 on HIV replication, 1 ug YU-2 plasmid was co-transfected with 3 ug of Anx2 or pcDNA 3.1. For BiFC, Anx2-FR1 and p41Gag-FR2 were co-transfected in the ratio of 1 ug Anx2 or CD63: 2 ug p41Gag or Gag along with 1 ug empty vector, 5ptase IV, or Arf6/Q67L.
###end p 56
###begin title 57
Bimolecular fluorescence complementation (BiFC) and Immunofluorescence
###end title 57
###begin p 58
###xml 159 164 <span type="species:ncbi:10090">mouse</span>
###xml 223 229 <span type="species:ncbi:9986">rabbit</span>
###xml 290 296 <span type="species:ncbi:9986">rabbit</span>
###xml 381 388 <span type="species:ncbi:9031">chicken</span>
###xml 394 399 <span type="species:ncbi:10090">mouse</span>
###xml 408 414 <span type="species:ncbi:9986">rabbit</span>
Thirty-six hours after transfection, 293T cells were fixed in 4% paraformaldehyde in PBS and permeabilized with 0.1% Triton-X. Gag-YFP2 was immunolabeled with mouse anti-GFP (Roche Applied Science, Germany), 5ptase IV with rabbit anti-c-Myc (A-14) antibody (Santa Cruz), and Arf6/Q67L with rabbit anti-HA-probe (Y-11; Santa Cruz). Cells were then incubated with Alexa Fluor(R) 488 chicken anti-mouse or anti-rabbit IgG (Invitrogen), stained with DAPI (4',6'-diamidino-2-phenylindole; Invitrogen) and coverslipped with ProLong(R) Gold antifade reagent (Invitrogen). For collocation with GM1, cells were stained with recombinant cholera toxin B (CTB) conjugated to Alexa Fluor(R) 594 after fixation and CTB was then aggregated using anti-CTB antibody (Vybrant(R) Lipid Raft Labeling kit, Invitrogen). Fluorescence in the cells was analyzed using a Zeiss LSM 510 confocal microscope. Images were taken with a LSM 510 camera and processed with Adobe Photoshop CS.
###end p 58
###begin title 59
Membrane flotation
###end title 59
###begin p 60
###xml 57 61 57 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Ono4">[62]</xref>
###xml 62 66 62 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005020-Spearman1">[64]</xref>
###xml 869 872 855 858 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF2</sub>
###xml 876 879 862 865 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 828 834 <span type="species:ncbi:9986">rabbit</span>
###xml 864 867 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 957 962 <span type="species:ncbi:10090">mouse</span>
###xml 1003 1008 <span type="species:ncbi:10090">mouse</span>
###xml 1014 1019 <span type="species:ncbi:9606">Human</span>
###xml 1080 1085 <span type="species:ncbi:10090">mouse</span>
Membrane flotation was performed as described previously [62]-[64]. Thirty-six hours post-transfection, 293T cells were lysed in Tris-EDTA (TE) buffer (10 mM Tris-HCl pH 7.5 with 1 mM EDTA) containing 1% Triton X-100, 6% sucrose, and protease inhibitors. Post-nuclear supernatants (PNS) were obtained by low-speed centrifugation and 250 microL were adjusted to 73.3% sucrose with 1.25 mL 85.5% sucrose in TE. The lysates were overlaid with 7 mL 65% sucrose in TE and 3.25 mL 10% sucrose in TE before ultracentrifugation at 100,000xg for 18-24 hrs at 4degreesC. Twelve 1 mL fractions were collected from the top, and 150 microL fractions were combined in pairs and proteins concentrated using the Pierce SDS-PAGE Sample Prep Kit according to the manufacturer's protocol. Fractions were analyzed by SDS-PAGE and western blot with rabbit polyclonal antiserum against HIV-1SF2 p24Gag (AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH), mouse anti-Anx2 (BD Biosciences, New Jersey), mouse anti-Human Transferrin Receptor (Zymed, Invitrogen, Carlsbad, CA), and mouse anti-Flotillin-1 (BD Biosciences).
###end p 60
###begin title 61
Virus precipitation and analysis
###end title 61
###begin p 62
###xml 269 272 269 272 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 284 287 284 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 315 318 315 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 855 858 851 854 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SF2</sub>
###xml 862 865 858 861 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 264 267 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 814 820 <span type="species:ncbi:9986">rabbit</span>
###xml 850 853 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 943 948 <span type="species:ncbi:10090">mouse</span>
###xml 1013 1019 <span type="species:ncbi:9986">rabbit</span>
Peripheral blood mononuclear cells derived from whole blood by the University of Pennsylvania Center CFAR Immunology core were plated (3.2 million cells/well) in six-well plates and differentiated into macrophages for seven days. 293T cell supernatants containing HIV-1YU2 (200 ng p24Gag per well as measured by p24Gag ELISA) were applied to the monocyte-derived macrophages (MDMs) for 48 hours, and infected MDM supernatants were collected 11 days after infection. Cellular material was pelleted by centrifuging the supernatants for 1 min at 16,100xg and then 1 mL of each clarified supernatant was passed through 0.45 microm filters to further remove any cellular components. Virus pellets were obtained by ultracentrifugation of the filtered supernatants and then analyzed by SDS-PAGE and western blotting with rabbit polyclonal antiserum against HIV-1SF2 p24Gag (AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH), mouse monoclonal anti-Anx2 antibody (BD Biosciences, New Jersey), and rabbit polyclonal anti-GAPDH antibody (Abcam, Cambridge, MA). Virus pellets from transfected 293T cells were prepared and analyzed in the same manner.
###end p 62
###begin title 63
Virus immunoprecipitation from cell supernatants
###end title 63
###begin p 64
###xml 65 68 65 68 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 1097 1100 1046 1049 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 60 63 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 507 510 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 527 530 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1054 1059 <span type="species:ncbi:10090">mouse</span>
###xml 1088 1093 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1188 1193 <span type="species:ncbi:10090">mouse</span>
Supernatants from 293T cells transfected with Anx2 alone or HIV-1YU2+Anx2 were collected 36 hours post-transfection. Before immunoprecipitation, the cellular debris was pelleted by centrifugation for 1 min at 16000xg. 900 microL of each supernatant was then added to 100 microL of PBS only or to 100 uL 5% Triton-X in PBS to lyse the virions. The supernatants were pre-cleared with 50 microL recombinant protein G agarose (Invitrogen, Carlsbad, CA) at 4degreesC for one hour before incubation with 5 microL HIV Immunoglobulin (HIV-IGtrade mark from AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH) overnight at 4degreesC. Fifty microL of fresh protein G beads were then added to the supernatant-antibody mixture and incubated for 2 hr at 4degreesC. The beads were washed twice in 0.5% Triton-X in PBS, once in PBS, resuspended in 50 microL 2x SDS buffer and boiled for 5 min. Equal volumes of immunoprecipitates were subjected to SDS-PAGE on 8-16% Tris-Glycine polyacrylamide gels (Lonza, Switzerland) and western blotting with mouse monoclonal antibody against HIV-1 p24Gag (#24-2, AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH) and mouse monoclonal anti-Anx2 antibody (BD Biosciences, New Jersey).
###end p 64
###begin title 65
Western blotting for Anx2 expression and Gag Processing
###end title 65
###begin p 66
###xml 90 93 90 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 258 260 258 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DC</italic>
###xml 85 88 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 399 402 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 419 422 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 517 522 <span type="species:ncbi:10090">mouse</span>
###xml 563 568 <span type="species:ncbi:10090">mouse</span>
###xml 627 633 <span type="species:ncbi:9986">rabbit</span>
293T cells at 36 hours post-transfection and MDMs at 10-14 days after infection with HIV-1YU2 were lysed in 0.5% Triton-X in PBS with protease inhibitors (Complete, Roche Applied Science, Germany) and protein concentrations were determined using the Bio-Rad DC Protein Assay kit. Equal micrograms of each sample were analyzed by SDS-PAGE and western blot. Antibodies used for protein detection were HIV Immunoglobulin (HIV-IGtrade mark from AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH), mouse anti-Anx2 (BD Biosciences, New Jersey), mouse monoclonal against beta actin (Abcam, Cambridge, MA), and rabbit polyclonal against GAPDH (Abcam, Cambridge, MA). NIH Image J was used to quantify bands. Statistical analysis was performed using a two-tailed paired student's t test.
###end p 66
###begin title 67
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
p24Gag protein measurement
###end title 67
###begin p 68
###xml 304 307 304 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
###xml 623 626 623 626 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 663 666 663 666 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 618 621 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 658 661 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
36 hours post-transfection of 293T cells, supernatants were collected and the cells were lysed in 0.5% Triton-X in PBS supplemented with protease inhibitors (Complete; Roche Applied Science, Germany). The Gag concentration in the supernatants and cell lysates was measured in our laboratory using the p24Gag enzyme-linked immunosorbent assay (ELISA) as per the manufacturer's instructions (Perkin-Elmer; NEK050) or by the University of Pennsylvania Center for AIDS Research (CFAR) Virus and Molecular Core. The effect of Anx2 overexpression on Gag concentration was calculated as the ratio of the experimental values (HIV-1YU2+Anx2) over the control values (HIV-1YU2+vector) with control values set to one. Statistical analysis was performed on the ratios using a paired two-tailed student's t-test. Error bars represent standard errors of the mean.
###end p 68
###begin title 69
Quantification of infectious virus in 293T supernatants
###end title 69
###begin p 70
###xml 406 409 403 406 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 426 429 423 426 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">YU2</sub>
###xml 135 140 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 401 404 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 421 424 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
TZM-bl cells are CD4- and CCR5-expressing HeLa cells that contain the luciferase and beta-galactosidase genes under the control of the HIV-1 promoter (obtained from the NIH AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH: from Dr. John C. Kappes, Dr. Xiaoyun Wu, and Tranzyme Inc.) TZM-bl cells in 96-well plates were incubated with 5 uL of virus-containing supernatant from HIV-1YU2+Vector and HIV-1YU2+Anx2 transfected 293T cells. Supernatants from three independent transfections were used. After 24 hours of incubation, the media was removed and the cells were lysed by exposure to 25 uL 1x Reporter Lysis Buffer (Promega, Madison, Wisconsin) followed by one freeze-thaw cycle. One-hundred microliters of Luciferase Assay Substrate (Promega) was added to each well and the relative light units (RLU) were measured using a Packard LumiCount luminometer and Packard PlateReader 3.0 software. Statistical analysis was performed using an unpaired two-tailed student's t-test.
###end p 70
###begin p 71
###xml 374 377 374 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gag</sup>
Several reagents were obtained from the NIH AIDS Research and Reference Reagents Program. We thank Yuri Veklich and the LSCM facility in the Department of Cell and Developmental Biology (University of Pennsylvania) and Kelly Jordan-Sciutto in the Department of Pathology (University of Pennsylvania) for help with the confocal microscopy experiments. For assistance with p24Gag ELISAs and virus precipitation we thank Farida Shaheen of the CFAR. Dr. Peter Yang of the CFAR Biostatistics and Data Management Core assisted with statistics. We specially thank Samantha S. Soldan for her excellent feedback during the course of performing these experiments and in reviewing this manuscript.
###end p 71
###begin title 72
References
###end title 72
###begin article-title 73
###xml 30 33 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Updated research nosology for HIV-associated neurocognitive disorders.
###end article-title 73
###begin article-title 74
Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS.
###end article-title 74
###begin article-title 75
###xml 66 69 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 123 126 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection.
###end article-title 75
###begin article-title 76
The neuropathogenesis of AIDS.
###end article-title 76
###begin article-title 77
###xml 51 56 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 74 79 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals.
###end article-title 77
###begin article-title 78
###xml 41 69 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Early viral brain invasion in iatrogenic human immunodeficiency virus infection.
###end article-title 78
###begin article-title 79
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 pathogenesis.
###end article-title 79
###begin article-title 80
###xml 16 21 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Macrophages and HIV-1: dangerous liaisons.
###end article-title 80
###begin article-title 81
###xml 19 54 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Annexin 2: a novel human immunodeficiency virus type 1 Gag binding protein involved in replication in monocyte-derived macrophages.
###end article-title 81
###begin article-title 82
###xml 24 29 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells.
###end article-title 82
###begin article-title 83
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 assembly, release, and maturation.
###end article-title 83
###begin article-title 84
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 104 109 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 assembly: viral glycoproteins segregate quantally to lipid rafts that associate individually with HIV-1 capsids and virions.
###end article-title 84
###begin article-title 85
###xml 29 64 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Gag regulates association of human immunodeficiency virus type 1 envelope with detergent-resistant membranes.
###end article-title 85
###begin article-title 86
###xml 14 17 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Modulation of HIV-like particle assembly in vitro by inositol phosphates.
###end article-title 86
###begin article-title 87
###xml 19 54 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Multimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains.
###end article-title 87
###begin article-title 88
###xml 16 19 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 89 92 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1.
###end article-title 88
###begin article-title 89
###xml 16 19 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Lipid rafts and HIV pathogenesis: virion-associated cholesterol is required for fusion and infection of susceptible cells.
###end article-title 89
###begin article-title 90
###xml 24 59 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts.
###end article-title 90
###begin article-title 91
###xml 46 51 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Plasma membrane rafts play a critical role in HIV-1 assembly and release.
###end article-title 91
###begin article-title 92
###xml 50 55 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane.
###end article-title 92
###begin article-title 93
###xml 31 36 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly.
###end article-title 93
###begin article-title 94
###xml 24 59 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Interaction between the human immunodeficiency virus type 1 Gag matrix domain and phosphatidylinositol-(4,5)-bisphosphate is essential for efficient gag membrane binding.
###end article-title 94
###begin article-title 95
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Gag: flipped out for PI(4,5)P(2).
###end article-title 95
###begin article-title 96
###xml 96 131 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Depletion of cellular cholesterol inhibits membrane binding and higher-order multimerization of human immunodeficiency virus type 1 Gag.
###end article-title 96
###begin article-title 97
###xml 13 16 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane.
###end article-title 97
###begin article-title 98
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 egress is gated through late endosomal membranes.
###end article-title 98
###begin article-title 99
###xml 79 84 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Mapping of tetraspanin-enriched microdomains that can function as gateways for HIV-1.
###end article-title 99
###begin article-title 100
Mechanisms of enveloped RNA virus budding.
###end article-title 100
###begin article-title 101
###xml 61 66 <span type="species:ncbi:9606">human</span>
Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages.
###end article-title 101
###begin article-title 102
###xml 39 44 <span type="species:ncbi:9606">human</span>
Plasmin triggers cytokine induction in human monocyte-derived macrophages.
###end article-title 102
###begin article-title 103
Annexin A2 is a soluble mediator of macrophage activation.
###end article-title 103
###begin article-title 104
###xml 86 91 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection.
###end article-title 104
###begin article-title 105
Annexin II is a major component of fusogenic endosomal vesicles.
###end article-title 105
###begin article-title 106
The biogenesis of multivesicular endosomes.
###end article-title 106
###begin article-title 107
Annexin II regulates multivesicular endosome biogenesis in the degradation pathway of animal cells.
###end article-title 107
###begin article-title 108
The subcellular distribution of early endosomes is affected by the annexin II2p11(2) complex.
###end article-title 108
###begin article-title 109
The annexin 2/S100A10 complex controls the distribution of transferrin receptor-containing recycling endosomes.
###end article-title 109
###begin article-title 110
Cholesterol regulates membrane binding and aggregation by annexin 2 at submicromolar Ca(2+) concentration.
###end article-title 110
###begin article-title 111
Annexins in cell membrane dynamics. Ca(2+)-regulated association of lipid microdomains.
###end article-title 111
###begin article-title 112
Annexin 2 promotes the formation of lipid microdomains required for calcium-regulated exocytosis of dense-core vesicles.
###end article-title 112
###begin article-title 113
Lipid rafts, detergent-resistant membranes, and raft targeting signals.
###end article-title 113
###begin article-title 114
Functions of lipid rafts in biological membranes.
###end article-title 114
###begin article-title 115
Lipid rafts and membrane traffic.
###end article-title 115
###begin article-title 116
Lipid rafts and the regulation of exocytosis.
###end article-title 116
###begin article-title 117
Phosphoinositide specificity of and mechanism of lipid domain formation by annexin A2-p11 heterotetramer.
###end article-title 117
###begin article-title 118
###xml 10 13 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Low-level HIV replication in mixed glial cultures is associated with alterations in the processing of p55(Gag).
###end article-title 118
###begin article-title 119
###xml 14 17 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Evidence that HIV budding in primary macrophages occurs through the exosome release pathway.
###end article-title 119
###begin article-title 120
###xml 41 69 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 99 104 <span type="species:ncbi:9606">human</span>
###xml 141 146 <span type="species:ncbi:9606">human</span>
Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study.
###end article-title 120
###begin article-title 121
###xml 11 16 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Infectious HIV-1 assembles in late endosomes in primary macrophages.
###end article-title 121
###begin article-title 122
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 29 34 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Human macrophages accumulate HIV-1 particles in MHC II compartments.
###end article-title 122
###begin article-title 123
###xml 47 82 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages.
###end article-title 123
###begin article-title 124
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 88 91 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The trans-Golgi network-associated human ubiquitin-protein ligase POSH is essential for HIV type 1 production.
###end article-title 124
###begin article-title 125
###xml 42 77 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The host protein Staufen1 participates in human immunodeficiency virus type 1 assembly in live cells by influencing pr55Gag multimerization.
###end article-title 125
###begin article-title 126
###xml 33 68 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Identification of Staufen in the human immunodeficiency virus type 1 Gag ribonucleoprotein complex and a role in generating infectious viral particles.
###end article-title 126
###begin article-title 127
###xml 60 95 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Major histocompatibility complex class II molecules promote human immunodeficiency virus type 1 assembly and budding to late endosomal/multivesicular body compartments.
###end article-title 127
###begin article-title 128
###xml 0 6 <span type="species:ncbi:171251">Citron</span>
###xml 41 46 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Citron kinase, a RhoA effector, enhances HIV-1 virion production by modulating exocytosis.
###end article-title 128
###begin article-title 129
###xml 67 102 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidation.
###end article-title 129
###begin article-title 130
###xml 41 46 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 118 123 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
SOCS1 is an inducible host factor during HIV-1 infection and regulates the intracellular trafficking and stability of HIV-1 Gag.
###end article-title 130
###begin article-title 131
###xml 80 115 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation.
###end article-title 131
###begin article-title 132
###xml 30 65 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 98 103 <span type="species:ncbi:9606">human</span>
Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes.
###end article-title 132
###begin article-title 133
###xml 4 7 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The HIV lipidome: a raft with an unusual composition.
###end article-title 133
###begin article-title 134
###xml 11 46 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus.
###end article-title 134
###begin article-title 135
###xml 43 78 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.
###end article-title 135
###begin article-title 136
###xml 20 55 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism.
###end article-title 136
###begin article-title 137
Visualization of molecular interactions by fluorescence complementation.
###end article-title 137
###begin article-title 138
Capturing protein interactions in the secretory pathway of living cells.
###end article-title 138
###begin article-title 139
###xml 52 57 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 62 67 <span type="species:ncbi:11709?0.8305084745762712">HIV-2</span>
###xml 82 87 <span type="species:ncbi:9606">human</span>
Coassembly and complementation of Gag proteins from HIV-1 and HIV-2, two distinct human pathogens.
###end article-title 139
###begin article-title 140
###xml 38 68 <span type="species:ncbi:11665">equine infectious anemia virus</span>
###xml 73 108 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Distinct intracellular trafficking of equine infectious anemia virus and human immunodeficiency virus type 1 Gag during viral assembly and budding revealed by bimolecular fluorescence complementation assays.
###end article-title 140
###begin article-title 141
The crystal structure of a complex of p11 with the annexin II N-terminal peptide.
###end article-title 141
###begin article-title 142
###xml 11 46 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane.
###end article-title 142
###begin article-title 143
###xml 23 28 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 32 37 <span type="species:ncbi:9606">human</span>
Assembly of infectious HIV-1 in human epithelial and T-lymphoblastic cell lines.
###end article-title 143
###begin article-title 144
###xml 42 47 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Plasma membrane is the site of productive HIV-1 particle assembly.
###end article-title 144
###begin article-title 145
###xml 31 66 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Dynamic fluorescent imaging of human immunodeficiency virus type 1 gag in live cells by biarsenical labeling.
###end article-title 145
###begin article-title 146
###xml 14 49 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Modulation of human immunodeficiency virus type 1 infectivity through incorporation of tetraspanin proteins.
###end article-title 146
###begin article-title 147
Membrane receptors for bacterial toxins.
###end article-title 147
###begin article-title 148
Evaluation by dot-immunoassay of the differential distribution of cell surface and intracellular proteins in glycosylphosphatidylinositol-rich plasma membrane domains.
###end article-title 148
###begin article-title 149
Lipid domain structure of the plasma membrane revealed by patching of membrane components.
###end article-title 149
###begin article-title 150
Visualization of phosphoinositides that bind pleckstrin homology domains: calcium- and agonist-induced dynamic changes and relationship to myo-[3H]inositol-labeled phosphoinositide pools.
###end article-title 150
###begin article-title 151
ARF6 regulates a plasma membrane pool of phosphatidylinositol(4,5)bisphosphate required for regulated exocytosis.
###end article-title 151
###begin article-title 152
Phosphatidylinositol 4,5-bisphosphate and Arf6-regulated membrane traffic.
###end article-title 152
###begin article-title 153
Annexin 2 binding to phosphatidylinositol 4,5-bisphosphate on endocytic vesicles is regulated by the stress response pathway.
###end article-title 153
###begin article-title 154
Phosphoinositide-specific inositol polyphosphate 5-phosphatase IV inhibits Akt/protein kinase B phosphorylation and leads to apoptotic cell death.
###end article-title 154
###begin article-title 155
###xml 19 54 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Sensitivity of the human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120.
###end article-title 155
###begin article-title 156
###xml 98 133 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.
###end article-title 156
###begin article-title 157
###xml 23 58 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 62 70 <span type="species:ncbi:9606">patients</span>
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.
###end article-title 157
###begin article-title 158
###xml 33 68 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body.
###end article-title 158
###begin article-title 159
###xml 20 55 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of gag membrane targeting.
###end article-title 159
###begin article-title 160
###xml 52 57 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Entropic switch regulates myristate exposure in the HIV-1 matrix protein.
###end article-title 160
###begin article-title 161
###xml 15 50 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Association of human immunodeficiency virus type 1 gag with membrane does not require highly basic sequences in the nucleocapsid: use of a novel Gag multimerization assay.
###end article-title 161
###begin article-title 162
###xml 39 44 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Time course of Gag protein assembly in HIV-1-infected cells: a study by immunoelectron microscopy.
###end article-title 162
###begin article-title 163
Annexin 2 is a phosphatidylinositol (4,5)-bisphosphate binding protein recruited to actin assembly sites at cellular membranes.
###end article-title 163
###begin article-title 164
###xml 28 31 <span type="species:ncbi:103820">Gag</span>
###xml 32 35 <span type="species:ncbi:103820">Gag</span>
Role of RNA in facilitating Gag/Gag-Pol interaction.
###end article-title 164
###begin article-title 165
###xml 16 21 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53.
###end article-title 165
###begin article-title 166
Aggregation of chromaffin granules by calpactin at micromolar levels of calcium.
###end article-title 166
###begin article-title 167
Structural analysis of junctions formed between lipid membranes and several annexins by cryo-electron microscopy.
###end article-title 167
###begin article-title 168
Calcium-dependent self-association of annexin II: a possible implication in exocytosis.
###end article-title 168
###begin article-title 169
Calcium-dependent fusion among endosomes.
###end article-title 169
###begin article-title 170
Conformational change and localization of calpactin I complex involved in exocytosis as revealed by quick-freeze, deep-etch electron microscopy and immunocytochemistry.
###end article-title 170
###begin article-title 171
Quick-freeze, deep-etch visualization of exocytosis in anterior pituitary secretory cells: localization and possible roles of actin and annexin II.
###end article-title 171
###begin article-title 172
Annexin 2-mediated enhancement of cytomegalovirus infection opposes inhibition by annexin 1 or annexin 5.
###end article-title 172
###begin article-title 173
Annexin II enhances cytomegalovirus binding and fusion to phospholipid membranes.
###end article-title 173
###begin article-title 174
The C terminus of annexin II mediates binding to F-actin.
###end article-title 174
###begin article-title 175
###xml 37 55 <span type="species:ncbi:11886">Rous sarcoma virus</span>
Identity of p36K phosphorylated upon Rous sarcoma virus transformation with a protein purified from brush borders; calcium-dependent binding to non-erythroid spectrin and F-actin.
###end article-title 175
###begin article-title 176
Regulation of actin dynamics by annexin 2.
###end article-title 176
###begin article-title 177
Annexins-unique membrane binding proteins with diverse functions.
###end article-title 177
###begin article-title 178
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV accomplices and adversaries in macrophage infection.
###end article-title 178
###begin article-title 179
###xml 23 48 <span type="species:ncbi:11855">Mason-Pfizer monkey virus</span>
###xml 101 106 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Multiple copies of the Mason-Pfizer monkey virus constitutive RNA transport element lead to enhanced HIV-1 Gag expression in a context-dependent manner.
###end article-title 179
###begin p 180
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 180
###begin p 181
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Supported by PHS Grant NS-27405; A.V.H. is supported by Ruth L. Kirschstein National Research Service Award F30 NS055523 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health. This publication was made possible through core services and support from the Penn Center for AIDS Research (CFAR) (P30 AI 045008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 181

